Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
Corewell Health East
360 participants
Nov 7, 2023
INTERVENTIONAL
Conditions
Summary
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Eligibility
Inclusion Criteria8
- ≥ than 18 years old Vascular Access Score of 4 or 5
- Vascular Access Score:
- Visible with distention and easily palpable
- Visible and easily palpable
- Not visible and easily palpable
- Visible and poorly palpable
- Not visible and poorly or non-palpable
- Clinician working in the emergency department at Corewell Health William Beaumont University Hospital (physician, advanced practice provider, nurse, technician) Competency in Operation STICK, which is an vascular access training program.
Exclusion Criteria2
- \<18 years old Restricted mobility of elbow joint Cognitively impaired. Skin complications that limit access to the potential IV site
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
B Braun Medical Inc, 6.35cm 20 gauge ultralong intravenous catheter
Bard Access Systems, Inc, BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06107361